Why Cognex Corporation (CGNX) Stock Is Down Today

Cognex Corporation (CGNX) is down 3.2% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely explanation is a valuation-driven pullback rather than a new company-specific shock. Cognex had entered the session after a strong run, and investors may be taking profits even though the company’s most recent operating results and near-term outlook were solid. This could also be because the stock had climbed well above earlier analyst target levels, leaving less room for upside in the short term.

Details:

Cognex’s latest reported quarter showed strong year-over-year growth in revenue, earnings, and adjusted profitability, which had helped lift sentiment earlier.

Management’s second-quarter 2026 guidance called for revenue of $280 million to $300 million and adjusted diluted earnings per share of $0.40 to $0.44, reinforcing expectations for continued growth.

The stock closed near $60.78 on August 12, 2026 after trading as high as $64.40 intraday, a sharp reversal that fits a profit-taking pattern more than a fundamental reset.

A recent analyst target increase still noted that much of the good news appeared to be priced in, which may have encouraged investors to lock in gains after the rally.

Sources:

Cognex Investor Relations, SEC, Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CGNX Insider Trading Activity

$CGNX insiders have traded $CGNX stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.

Here’s a breakdown of recent trading of $CGNX stock by insiders over the last 6 months:

ROBERT WILLETT has made 0 purchases and 3 sales selling 179,200 shares for an estimated $10,465,007.
JOERG KUECHEN (Head of Corporate M&A) has made 0 purchases and 4 sales selling 61,900 shares for an estimated $3,468,385.
DARREN MARC LONG (Vice President) has made 0 purchases and 4 sales selling 20,252 shares for an estimated $1,343,456.
LAURA ANN MACDONALD (VP and PAO) has made 0 purchases and 2 sales selling 14,881 shares for an estimated $850,553.
CARL GERST (EVP, Global Sales and Products) has made 0 purchases and 2 sales selling 14,336 shares for an estimated $802,021.
ANGELOS PAPADIMITRIOU sold 4,150 shares for an estimated $230,658

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive CGNX Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$CGNX Hedge Fund Activity

We have seen 361 institutional investors add shares of $CGNX stock to their portfolio, and 261 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO removed 10,451,742 shares (-99.8%) from their portfolio in Q1 2026, for an estimated $512,030,840
MACKENZIE FINANCIAL CORP removed 1,817,037 shares (-69.5%) from their portfolio in Q1 2026, for an estimated $89,016,642
POINT72 ASSET MANAGEMENT, L.P. removed 1,580,967 shares (-42.6%) from their portfolio in Q1 2026, for an estimated $77,451,573
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 1,090,092 shares (+115.6%) to their portfolio in Q1 2026, for an estimated $53,403,607
MUNRO PARTNERS added 1,046,750 shares (+inf%) to their portfolio in Q2 2026, for an estimated $75,805,635
PICTET ASSET MANAGEMENT HOLDING SA removed 843,153 shares (-12.6%) from their portfolio in Q2 2026, for an estimated $61,061,140
SUMITOMO MITSUI TRUST GROUP, INC. added 805,210 shares (+57.1%) to their portfolio in Q2 2026, for an estimated $58,313,308

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CGNX Analyst Ratings

Wall Street analysts have issued reports on $CGNX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Needham issued a "Buy" rating on 05/08/2026

To track analyst ratings and price targets for $CGNX, check out Quiver Quantitative's $CGNX forecast page.

$CGNX Price Targets

Multiple analysts have issued price targets for $CGNX recently. We have seen 9 analysts offer price targets for $CGNX in the last 6 months, with a median target of $75.0.

Here are some recent targets:

Jamie Cook from Truist Securities set a target price of $71.0 on 07/02/2026
Tomohiko Sano from JP Morgan set a target price of $75.0 on 05/26/2026
Matthew Summerville from DA Davidson set a target price of $62.0 on 05/14/2026
Guy Hardwick from Barclays set a target price of $75.0 on 05/11/2026
Joe Ritchie from Goldman Sachs set a target price of $80.0 on 05/11/2026
James Ricchiuti from Needham set a target price of $75.0 on 05/08/2026
Piyush Avasthy from Citigroup set a target price of $68.0 on 05/08/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.